1.http: //www. Who. int/mediacentre/factsheets/fs164/en//, 2014.
2.TianZ. Outflanking HCV[J]. Nat Immunol. 2014;15(1): 6‐8.
3. Shakeri MT, Nomani H, Ghayour Mobarhan M, Sima HR, Gerayli S, Shahbazi S, et al. The prevalence of hepatitis C virus in mashhad, iran: a population-based study. Hepat Mon. 2013; 13(3): e7723.
4. Merat S, Rezvan H, Nouraie M, Jafari E, Abolghasemi H, Radmard AR, et al. Seroprevalence of hepatitis C virus: the first populationbased study from Iran. Int J Infect Dis. 2010; 14 Suppl 3:e113–16.
5. Alavian SM, Kabir A, Ahmadi AB, Lankarani KB, Shahbabaie MA, Ahmadzad-Asl M. Hepatitis C infection in hemodialysis patients in Iran: a systematic review. Hemodial Int. 2010; 14(3):253–62.
6. Dai Z. Viral Hepatitis in China sero-epidemiological survey in Chinese population; G Qi. Beijing: Science and Technology. 1995.
7. Xia GL, Liu CB, Cao HL, Bi SL, Zhan MY, Su CA, et al. Prevalence of hepatitis B and C virus infections in the general Chinese population. Results from a nationwide cross-sectional seroepidemiologic study of hepatitis A, B, C, D, and E virus infections in China, 1992. Int Hepatol Commun. 1996; 5: 62-73.
8. Fox AN, Jacobson IM. Recent successes and noteworthy future prospects in the treatment of chronic hepatitis C. Clin Infect Dis. 2012; 55 (Suppl 1):S16-24.
9. Min Zhou, Hong Li, Yulin Ji, Yuanji Ma, Fengsu Hou, Ping Yuan: Hepatitis C virus infection in the general population. A large community -based study in Mianyang, West China. BioScience Trends Trends. 2015; 9(2):97-103.
10. Yuliang Zhao, Liping Shen, Jingchen Ma, Zhao Gao, Xu Han, Shunxiang Qi, et al. Epidemiology of Hepatitis C Virus Infection and Risk Factor Analysis in the Hebei Province, China. PLOS ONG. 2013; 8(9):1-4.
11. Qin Q, Smith MK, Wang L, Su Y, Wang L, Guo W, et al. Hepatitis C virus infection in China: An emerging public health issue. J Viral Hepat. 2015; 22:238-44.
12. Zhao Y, Shen L, Ma J, Gao Z, Han X, Qi S, et al. Epidemiology of Hepatitis C Virus Infection and Risk Factor Analysis in the Hebei Province, China. PLoS ONE. 2013; 8: e75586.
13. Qian HZ, Yang Z, Shi X, Gao J, Xu C, Wang L, et al. Hepatitis C virus infection in formercommercial plasma/blood donors in rural Shanxi Province, China: The China Integrated Programs for Research on AIDS. J Infect Dis. 2005; 192:1694-1700.
14. Huang C, Qiu F, Guo M, Yi Y, Shen L, Wang F, et al. Prevalence and risk factors of hepatitis C among former blood donors in rural China. Int J Infect Dis. 2012; 16: e731-e34.
15. Shan H, Wang JX, Ren FR, Zhang YZ, Zhao HY, Gao GJ, et al. Blood banking in China. Lancet. 2002; 360:1770-75.
16. Li D, Long Y, Wang T, Xiao D, Zhang J, Guo Z, et al. Epidemiology of hepatitis C virus infection in highly endemic HBV areas in china. PLOS ONE. 2013; 8: e54815.
17. Prati D. Transmission of hepatitis C virus by blood transfusions and other medical procedures: a global review. J Hepatol. 2006; 45: 607-16.
18. Mohamed MK, Abdel-Hamid M, Mikhail NN, Abdel-Aziz F, Medhat A, Magder LS, et al. Intrafamilial transmission of hepatitis C in Egypt. Hepatology. 2005; 42:683–87.